Cargando…

Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients

BACKGROUND: hyperlipidemia as a major risk factor of atherosclerosis is treated with different drugs. Concerning length of therapy and vast majority of side effects, herbal medication may be suitable substitute for these drugs. METHODS: In this single-blind, placebo controlled study, lipid profiles...

Descripción completa

Detalles Bibliográficos
Autores principales: Kojuri, Javad, Vosoughi, Amir R, Akrami, Majid
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821028/
https://www.ncbi.nlm.nih.gov/pubmed/17328819
http://dx.doi.org/10.1186/1476-511X-6-5
_version_ 1782132670914887680
author Kojuri, Javad
Vosoughi, Amir R
Akrami, Majid
author_facet Kojuri, Javad
Vosoughi, Amir R
Akrami, Majid
author_sort Kojuri, Javad
collection PubMed
description BACKGROUND: hyperlipidemia as a major risk factor of atherosclerosis is treated with different drugs. Concerning length of therapy and vast majority of side effects, herbal medication may be suitable substitute for these drugs. METHODS: In this single-blind, placebo controlled study, lipid profiles of 150 hyperlipidemic patients in cardiology outpatient department of Shiraz University of Medical Sciences were checked at same conditions. They were divided into three equal groups randomly (each composing of 50 patients). They were given enteric-coated garlic powder tablet (equal to 400 mg garlic, 1 mg allicin) twice daily, anethum tablet (650 mg) twice daily, and placebo tablet. All patients were put on NCEP type Π diet and Six weeks later, lipid profiles were checked. RESULTS: In garlic group: total cholesterol (decreased by 26.82 mg/dl, 12.1% reduction, and P-value: .000), and LDL-cholesterol (decreased by 22.18 mg/dl, 17.3% reduction, and P-value: .000) dropped. HDL-cholesterol (increased by 10.02 mg/dl, 15.7% increase, and P-value: .000) increased. Although triglyceride dropped by 13.72 mg/dl (6.3%) but this was not significant statistically (P-value: .222). In anethum group: surprisingly, triglyceride increased by 14.74 mg/dl (6.0%). Anethum could reduce total cholesterol by 0.4 % and LDL-cholesterol by 6.3% but these were not significant statistically (P-value: .828, and .210, respectively). CONCLUSION: Anethum has no significant effect on lipid profile, but garlic tablet has significant favorable effect on cholesterol, LDL-cholesterol, and HDL-cholesterol. Garlic may play an important role in therapy of hypercholesterolemia.
format Text
id pubmed-1821028
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18210282007-03-14 Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients Kojuri, Javad Vosoughi, Amir R Akrami, Majid Lipids Health Dis Research BACKGROUND: hyperlipidemia as a major risk factor of atherosclerosis is treated with different drugs. Concerning length of therapy and vast majority of side effects, herbal medication may be suitable substitute for these drugs. METHODS: In this single-blind, placebo controlled study, lipid profiles of 150 hyperlipidemic patients in cardiology outpatient department of Shiraz University of Medical Sciences were checked at same conditions. They were divided into three equal groups randomly (each composing of 50 patients). They were given enteric-coated garlic powder tablet (equal to 400 mg garlic, 1 mg allicin) twice daily, anethum tablet (650 mg) twice daily, and placebo tablet. All patients were put on NCEP type Π diet and Six weeks later, lipid profiles were checked. RESULTS: In garlic group: total cholesterol (decreased by 26.82 mg/dl, 12.1% reduction, and P-value: .000), and LDL-cholesterol (decreased by 22.18 mg/dl, 17.3% reduction, and P-value: .000) dropped. HDL-cholesterol (increased by 10.02 mg/dl, 15.7% increase, and P-value: .000) increased. Although triglyceride dropped by 13.72 mg/dl (6.3%) but this was not significant statistically (P-value: .222). In anethum group: surprisingly, triglyceride increased by 14.74 mg/dl (6.0%). Anethum could reduce total cholesterol by 0.4 % and LDL-cholesterol by 6.3% but these were not significant statistically (P-value: .828, and .210, respectively). CONCLUSION: Anethum has no significant effect on lipid profile, but garlic tablet has significant favorable effect on cholesterol, LDL-cholesterol, and HDL-cholesterol. Garlic may play an important role in therapy of hypercholesterolemia. BioMed Central 2007-03-01 /pmc/articles/PMC1821028/ /pubmed/17328819 http://dx.doi.org/10.1186/1476-511X-6-5 Text en Copyright © 2007 Kojuri et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kojuri, Javad
Vosoughi, Amir R
Akrami, Majid
Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients
title Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients
title_full Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients
title_fullStr Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients
title_full_unstemmed Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients
title_short Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients
title_sort effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821028/
https://www.ncbi.nlm.nih.gov/pubmed/17328819
http://dx.doi.org/10.1186/1476-511X-6-5
work_keys_str_mv AT kojurijavad effectsofanethumgraveolensandgarliconlipidprofileinhyperlipidemicpatients
AT vosoughiamirr effectsofanethumgraveolensandgarliconlipidprofileinhyperlipidemicpatients
AT akramimajid effectsofanethumgraveolensandgarliconlipidprofileinhyperlipidemicpatients